Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Detection of Dysplastic Features by Multiparameter Flow Cytometry in Myelodysplastic Syndromes in Relation to Cytomorphology and Cytogenetics.

Wolfgang Kern, MD, Claudia Haferlach, M.D., Susanne Schnittger, Ph.D., Torsten Haferlach, M.D.

Blood (2007) 110 (11): 2461.

https://doi.org/10.1182/blood.V110.11.2461.2461

Published: 2007

Journal Articles

Microarray Classification of Myelodysplastic Syndrome (MDS) Identifies Subgroups with Distinct Clinical Outcomes.

Ken I. Mills, PhD, Alex Kohlmann, Ph.D., Mickey Williams, Ph.D., Wei-Min Liu, Ph.D., Rachel Li, David T. Bowen, M.D., Helmut Loeffler, M.D., Jesus M. Hernandez, M.D., Wolf-Karsten Hofmann, M.D., Torsten Haferlach, M.D., Lothar Wieczirek, Ph.D.

Blood (2007) 110 (11): 2426.

https://doi.org/10.1182/blood.V110.11.2426.2426

Published: 2007

Journal Articles

Genetic Profiling of Adult Acute Lymphoblastic Leukemia Cells by Single Nucleotide Polymorphism Oligonucleotide Microarray.

Ryoko Okamoto, PhD, Seishi Ogawa, M.D., Tadayuki Akagi, Ph.D., Motohiro Kato, M.D., Masashi Sanada, M.D., Carl W. Miller, Ph.D., Norihiko Kawamata, M.D., Claudia Haferlach, M.D., Torsten Haferlach, M.D., H. Phillip Koeffler, M.D.

Blood (2007) 110 (11): 2807.

https://doi.org/10.1182/blood.V110.11.2807.2807

Published: 2007

Journal Articles

Flow Cytometric Determination of ZAP-70 Expression by SBZAP Antibody: Impact of Type of Data Analysis on Correlation with IgVH Mutation Status, Cytogenetics, and Level of ZAP-70 mRNA Expression in 351 Patients with Chronic Lymphocytic Leukemia (CLL).

Wolfgang Kern, MD, Frank Dicker, Ph.D., Susanne Schnittger, Ph.D., Claudia Haferlach, M.D., Torsten Haferlach, M.D.

Blood (2007) 110 (11): 4682.

https://doi.org/10.1182/blood.V110.11.4682.4682

Published: 2007

Journal Articles

Correlation of Multiparameter Flow Cytometry and Fluorescence In Situ Hybridization in Quantifying Malignant Cells at Low Frequencies in B-Cell Lymphoproliferative Diseases.

Wolfgang Kern, MD, Torsten Haferlach, M.D., Susanne Schnittger, Ph.D., Claudia Haferlach, M.D.

Blood (2007) 110 (11): 4428.

https://doi.org/10.1182/blood.V110.11.4428.4428

Published: 2007

Journal Articles

Application of Multiparameter Flow Cytometry for the Identification of Dysplasia in Granulocytic, Monocytic, and Erythrocytic Lineages and Blasts in Patients with Myelodysplastic Syndromes.

Wolfgang Kern, MD, Claudia Schoch, M.D., Susanne Schnittger, Ph.D., Torsten Haferlach, M.D.

Blood (2006) 108 (11): 2615.

https://doi.org/10.1182/blood.V108.11.2615.2615

Published: 2006

Journal Articles

Correlation of Flow Cytometrically Determined Expression of ZAP-70 Using Two Different Antibodies with IgVH Mutation Status and Cytogenetics in 539 Patients with Chronic Lymphocytic Leukemia.

Wolfgang Kern, MD, Frank Dicker, Ph.D., Susanne Schnittger, Ph.D., Claudia Schoch, M.D., Torsten Haferlach, M.D.

Blood (2006) 108 (11): 495.

https://doi.org/10.1182/blood.V108.11.495.495

Published: 2006

Journal Articles

Use of 5-Fold Staining for Multiparameter Flow Cytometry-Based Quantification of Minimal Residual Disease in Acute Myeloid Leukemia Results in Improved Sensitivity.

Wolfgang Kern, M.D., Daniela Voskova, M.D., Claudia Schoch, M.D., Wolfgang Hiddemann, M.D., Susanne Schnittger, Ph.D., Torsten Haferlach, M.D.

Blood (2004) 104 (11): 2025.

https://doi.org/10.1182/blood.V104.11.2025.2025

Published: 2004

Journal Articles

Identification of Biologically Distinct and Clinically Relevant Subentities in Patients with Acute Myeloid Leukemia and Normal Karyotypes by Use of Gene Expression Profiling.

Wolfgang Kern, M.D., Claudia Schoch, M.D., Alexander Kohlmann, Ph.D., Martin Dugas, M.D., Sylvia Merk, M.D., Wolfgang Hiddemann, M.D., Susanne Schnittger, Ph.D., Torsten Haferlach, M.D.

Blood (2004) 104 (11): 195.

https://doi.org/10.1182/blood.V104.11.195.195

Published: 2004

Journal Articles

Flow Cytometric Characterization of Genetically Defined Subgroups of Chronic Lymphocytic Leukemia: Basis for the Comprehensive Definition of Prognostic Parameters.

Wolfgang Kern, M.D., Daniela Voskova, M.D., Claudia Schoch, M.D., Wolfgang Hiddemann, M.D., Susanne Schnittger, M.D., Torsten Haferlach, M.D.

Blood (2004) 104 (11): 4776.

https://doi.org/10.1182/blood.V104.11.4776.4776

Published: 2004

Journal Articles

Multiparameter Flow Cytometry Identifies Dysplasia in Granulocytic, Monocytic, and Erythrocytic Lineages and Blasts in Patients with Myelodysplastic Syndromes: Correlation with Cytomorphology and Cytogenetics.

Wolfgang Kern, M.D., Daniela Voskova, M.D., Claudia Schoch, M.D., Wolfgang Hiddemann, M.D., Susanne Schnittger, M.D., Torsten Haferlach, M.D.

Blood (2004) 104 (11): 2376.

https://doi.org/10.1182/blood.V104.11.2376.2376

Published: 2004

Journal Articles

Determination of Minimal Residual Disease in Patients with Acute Myeloid Leukemia by Multiparameter Flow Cytometry: Prognostic Impact at Different Checkpoints.

Wolfgang Kern, M.D., Daniela Voskova, M.D., Claudia Schoch, M.D., Wolfgang Hiddemann, M.D., Susanne Schnittger, Ph.D., Torsten Haferlach, M.D.

Blood (2004) 104 (11): 400.

https://doi.org/10.1182/blood.V104.11.400.400

Published: 2004

Journal Articles

Minimal Residual Disease in Patients with Acute Myeloid Leukemia Quantified by Multiparameter Flow Cytomety and Quantitative RT-PCR Is an Independent Prognostic Parameter.

Wolfgang Kern, M.D., Claudia Schoch, M.D., Torsten Haferlach, M.D., Daniela Voskova, M.D., Wolfgang Hiddemann, M.D., Susanne Schnittger, Ph.D.

Blood (2004) 104 (11): 319.

https://doi.org/10.1182/blood.V104.11.319.319

Published: 2004

Journal Articles

Gene Expression Profiling in Adult Acute Lymphoblastic Leukemia, Biphenotypic Acute Leukemia, and Acute Myeloid Leukemia M0: Confirmation of Immunophenotypic and Cytogenetic Diagnostic Findings.

Wolfgang Kern, M.D., Alexander Kohlmann, Claudia Schoch, M.D., Martin Dugas, M.D., Sylvia Merk, M.D., Wolfgang Hiddemann, M.D., Susanne Schnittger, Ph.D., Torsten Haferlach, M.D.

Blood (2004) 104 (11): 993.

https://doi.org/10.1182/blood.V104.11.993.993

Published: 2004

Journal Articles

Prognostic Impact of Cytogenetics and Early Response and Efficacy of Sequential High-Dose AraC and Idarubicin (S-HAI) in Patients with Refractory and Relapsed Acute Myeloid Leukemia (AML): Results of a Prospective Study.

Blood (2004) 104 (11): 871.

https://doi.org/10.1182/blood.V104.11.871.871

Published: 2004

NARROW

Detection of Dysplastic Features by Multiparameter Flow Cytometry in Myelodysplastic Syndromes in Relation to Cytomorphology and Cytogenetics.

Microarray Classification of Myelodysplastic Syndrome (MDS) Identifies Subgroups with Distinct Clinical Outcomes.

Genetic Profiling of Adult Acute Lymphoblastic Leukemia Cells by Single Nucleotide Polymorphism Oligonucleotide Microarray.

Flow Cytometric Determination of ZAP-70 Expression by SBZAP Antibody: Impact of Type of Data Analysis on Correlation with IgVH Mutation Status, Cytogenetics, and Level of ZAP-70 mRNA Expression in 351 Patients with Chronic Lymphocytic Leukemia (CLL).

Correlation of Multiparameter Flow Cytometry and Fluorescence In Situ Hybridization in Quantifying Malignant Cells at Low Frequencies in B-Cell Lymphoproliferative Diseases.

Application of Multiparameter Flow Cytometry for the Identification of Dysplasia in Granulocytic, Monocytic, and Erythrocytic Lineages and Blasts in Patients with Myelodysplastic Syndromes.

Correlation of Flow Cytometrically Determined Expression of ZAP-70 Using Two Different Antibodies with IgVH Mutation Status and Cytogenetics in 539 Patients with Chronic Lymphocytic Leukemia.

Use of 5-Fold Staining for Multiparameter Flow Cytometry-Based Quantification of Minimal Residual Disease in Acute Myeloid Leukemia Results in Improved Sensitivity.

Identification of Biologically Distinct and Clinically Relevant Subentities in Patients with Acute Myeloid Leukemia and Normal Karyotypes by Use of Gene Expression Profiling.

Flow Cytometric Characterization of Genetically Defined Subgroups of Chronic Lymphocytic Leukemia: Basis for the Comprehensive Definition of Prognostic Parameters.

Multiparameter Flow Cytometry Identifies Dysplasia in Granulocytic, Monocytic, and Erythrocytic Lineages and Blasts in Patients with Myelodysplastic Syndromes: Correlation with Cytomorphology and Cytogenetics.

Determination of Minimal Residual Disease in Patients with Acute Myeloid Leukemia by Multiparameter Flow Cytometry: Prognostic Impact at Different Checkpoints.

Minimal Residual Disease in Patients with Acute Myeloid Leukemia Quantified by Multiparameter Flow Cytomety and Quantitative RT-PCR Is an Independent Prognostic Parameter.

Gene Expression Profiling in Adult Acute Lymphoblastic Leukemia, Biphenotypic Acute Leukemia, and Acute Myeloid Leukemia M0: Confirmation of Immunophenotypic and Cytogenetic Diagnostic Findings.

Prognostic Impact of Cytogenetics and Early Response and Efficacy of Sequential High-Dose AraC and Idarubicin (S-HAI) in Patients with Refractory and Relapsed Acute Myeloid Leukemia (AML): Results of a Prospective Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only